Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD

Chronic Obstructive Pulmonary Disease Moderate Clinical Trial

Official title:

Effect of Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With Chronic Obstructive Pulmonary Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06269029
• Other study ID #: P.T.Rec/012/004297
• Status: Recruiting
• Phase: N/A
• Start date: February 17, 2024
• Est. completion date: June 30, 2024

Study information

• Verified date: April 2024
• Source: Cairo University
• Contact: Isaac Zarii, Master
• Phone: 01282937079
• Email: Isaaczakaria5[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Chest mobility exercise versus proprioceptive neuromuscular facilitation in patients with chronic obstructive pulmonary disease

Description:

The purpose of this study is designed to compare the therapeutic effect of chest mobility exercises and proprioceptive neuromuscular facilitation stretching on improving chest expansion and functional capacity in patients with chronicobstructivepulmonarydisease?

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: June 30, 2024
• Est. primary completion date: May 30, 2024
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 50 Years to 60 Years

Eligibility

Inclusion Criteria:

All patients will have the following criteria:

1. Age: 50-60 years old

2. All patients will be in mild to moderate of COPD. In accordance with criteria of Global Initiative for Chronic Obstructive Lung Disease (GOLD) (GOLD I-II).

3. BMI: obese class 1 (30-34.9).

4. Sex: male

5. They suffered from mild dyspnea, chronic cough and expectorations, with forced expiratory volume in one second (FEV1sec) from 50% to 80% of predicted value. Exclusion criteria:

Patients with the following criteria will excluded from the study:

1. Severe psychiatric or cognitive impairments.

2. Progressive neuromuscular disorders.

3. Decreased level of consciousness.

4. Unstable fracture.

5. pacemaker inserted for fewer than 2 days

6. Deep-venous thrombosis (to minimize risk for pulmonary embolism from being in a prone position.

7. Mean arterial blood pressure of less than 65 mm Hg with or without vasopressors.

8. Tracheal surgery or sternotomy in the last 15 days.

9. Massive haemoptysis.

10. Intracranial pressure of more than 30 mm Hg or cerebral perfusion pressure of less than 60 mm Hg.

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease Moderate
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• Chest mobility exercises
exercises were repeated 6 times on each side with rest of period for 30 seconds in between. The intervention will be carried out for one week with total of 7 sessions. Each Exercise will be accompanied by breathing pattern. In neutral position of exercises, subjects will be asked to exhale during flexion, turning or extension subject will be asked to do inhale.
• proprioceptive neuromuscular facilitation
The technique used in this study Proprioceptive neuromuscular facilitation technique of hold and relax stretching for isolated clavicular head of the pectoralis major muscle. The subjects sitting on a chair with back support to keep spine in a neutral position and both their arms are extended and hands are placed behind the occipital region. His both arms will be positioned in glenohumeral horizontal extension, and glenohumeral abduction and external rotation with elbow bent to perform stretch position of pectoral muscle. Then ask him to contract the pectoral muscles .This isometric contraction is held for 6 seconds. The patient then relaxed and passive stretch in the opposite direction . and it was repeated 6 times with rest period 30 seconds. The session will be given every day for one week

Locations

Country	Name	City	State
Egypt	Cairo university- faculty of physical therapy	Cairo	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pulmonary function test	Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and monitoring lung health Test started at the time of 20 minutes after subjects inhaling 400 µg of salbutamol. The following variables were assessed: FVC, FEV1, inspiratory capacity (IC), and inspiratory reserve volume (IRV)	One week for each comparator